OXB launches fast-track offering for AAV and lentiviral vector platforms, accelerating viral vector development and manufacture

New expedited service line designed for biotechs with timeline constraints, launched in response to client demandCan accelerate timeline to GMP ...

LumaCyte Analytical Method Included in Newly Published ISO Global Standard for Viral Vector Quantification

LumaCyte today announced that its analytical approach has been included in the newly published International Organization for Standardization (ISO) global standard for gene delivery systems, ISO 16921 ...
Pharmaceutical Technology

SIRION Biotech and Heidelberg University Hospital to Develop AAV Technologies

The viral vector specialist SIRION Biotech has announced the signing of a preferred partnership agreement with Heidelberg University Hospital ...
Business Insider

OXB enters into licensing agreement with Viral Vector Manufacturing Facility (VVMF), providing access to its AAV and LV viral vector platforms

Oxford, UK – 18 March 2026: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces that it has entered into a licensing and option agreement with Viral Vector ...
Des Moines Register

Creative Biolabs: Advancing Gene Therapy with Cutting-Edge Viral Vector Analysis

Creative Biolabs is helping researchers overcome challenges of gene therapy research by providing analytical testing and quality control services. SHIRLEY, NY, UNITED ...
The Desert Sun

Creative Biolabs: Advancing Gene Therapy with Cutting-Edge Viral Vector Analysis

* Viral Vector Analysis Services Creative Biolabs provides a full range of viral vector analytical solutions with advanced equipment and technology, including AAV vector analysis, lentiviral vector ...